Back to Journals » Neuropsychiatric Disease and Treatment » Volume 11

Neuropsychiatric Disease and Treatment


Archive: Volume 11, 2015

Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses

Bortolato B, Miskowiak KW, Köhler CA, Vieta E, Carvalho AF

Neuropsychiatric Disease and Treatment 2015, 11:3111-3125

Published Date: 17 December 2015

Cerebrospinal fluid biomarkers for Alzheimer’s disease: the role of apolipoprotein E genotype, age, and sex

Mehrabian S, Alexopoulos P, Ortner M, Traykov L, Grimmer T, Kurz A, Förstl H, Bickel H, Diehl-Schmid J

Neuropsychiatric Disease and Treatment 2015, 11:3105-3110

Published Date: 17 December 2015

Lack of tolerable treatment options for patients with schizophrenia

Citrome L, Eramo A, Francois C, Duffy R, Legacy SN, Offord SJ, Krasa HB, Johnston SS, Guiraud-Diawara A, Kamat SA, Rohman P

Neuropsychiatric Disease and Treatment 2015, 11:3095-3104

Published Date: 16 December 2015

Functional connectivity of paired default mode network subregions in primary insomnia

Nie X, Shao Y, Liu SY, Li HJ, Wan AL, Nie S, Peng DC, Dai XJ

Neuropsychiatric Disease and Treatment 2015, 11:3085-3093

Published Date: 16 December 2015

Disturbed spontaneous brain-activity pattern in patients with optic neuritis using amplitude of low-frequency fluctuation: a functional magnetic resonance imaging study

Huang X, Cai FQ, Hu PH, Zhong YL, Zhang Y, Wei R , Pei CG, Zhou FQ, Shao Y

Neuropsychiatric Disease and Treatment 2015, 11:3075-3083

Published Date: 16 December 2015

Altered intrinsic regional spontaneous brain activity in patients with optic neuritis: a resting-state functional magnetic resonance imaging study

Shao Y, Cai FQ, Zhong YL, Huang X, Zhang Y, Hu PH, Pei CG, Zhou FQ, Zeng XJ

Neuropsychiatric Disease and Treatment 2015, 11:3065-3073

Published Date: 11 December 2015

The effects of motivation feedback in patients with severe mental illness: a cluster randomized controlled trial

Jochems EC, van der Feltz-Cornelis CM, van Dam A, Duivenvoorden HJ, Mulder CL

Neuropsychiatric Disease and Treatment 2015, 11:3049-3064

Published Date: 11 December 2015

Coping strategies and quality of life in schizophrenia: cross-sectional study

Holubova M, Prasko J, Hruby R, Kamaradova D, Ociskova M, Latalova K, Grambal A

Neuropsychiatric Disease and Treatment 2015, 11:3041-3048

Published Date: 10 December 2015

Milnacipran treatment and potential biomarkers in depressed patients following an initial SSRI treatment failure: a prospective, open-label, 24-week study

Hashimoto T, Sakurai D, Oda Y, Hasegawa T, Kanahara N, Sasaki T, Komatsu H, Takahashi J, Oiwa T, Sekine Y, Watanabe H, Iyo M

Neuropsychiatric Disease and Treatment 2015, 11:3031-3040

Published Date: 10 December 2015

Severe arrhythmia induced by orally disintegrating aripiprazole tablets (Bosiqing®): a case report

Shao Q, Quan W, Jia X, Chen J, Ma S, Zhang X

Neuropsychiatric Disease and Treatment 2015, 11:3019-3021

Published Date: 9 December 2015

Asenapine for bipolar disorder

Scheidemantel T, Korobkova I, Rej S, Sajatovic M

Neuropsychiatric Disease and Treatment 2015, 11:3007-3017

Published Date: 4 December 2015

A review of cognitive conflicts research: a meta-analytic study of prevalence and relation to symptoms

Montesano A, López-González MA, Saúl LA, Feixas G

Neuropsychiatric Disease and Treatment 2015, 11:2997-3006

Published Date: 4 December 2015

Psychological changes in alcohol-dependent patients during a residential rehabilitation program

Giorgi I, Ottonello M, Vittadini G, Bertolotti G,

Neuropsychiatric Disease and Treatment 2015, 11:2989-2996

Published Date: 7 December 2015

Risk of seizures in transcranial magnetic stimulation: a clinical review to inform consent process focused on bupropion

Dobek CE, Blumberger DM, Downar J, Daskalakis ZJ, Vila-Rodriguez F

Neuropsychiatric Disease and Treatment 2015, 11:2975-2987

Published Date: 30 November 2015

Profile of brivaracetam and its potential in the treatment of epilepsy

Ferlazzo E, Russo E, Mumoli L, Sueri C, Gasparini S, Palleria C, Labate A, Gambardella A, De Sarro G, Aguglia U

Neuropsychiatric Disease and Treatment 2015, 11:2967-2973

Published Date: 30 November 2015

Long-term effect of early-life stress from earthquake exposure on working memory in adulthood

Li N, Wang Y, Zhao X, Gao Y, Song M, Yu L, Wang L, Li N, Chen Q, Li Y, Cai J, Wang X

Neuropsychiatric Disease and Treatment 2015, 11:2959-2965

Published Date: 26 November 2015

Japanese version of the Munich Parasomnia Screening: translation and linguistic validation of a screening instrument for parasomnias and nocturnal behaviors

Komada Y, Breugelmans R, Fulda S, Nakano S, Watanabe A, Noda C, Nishida S, Inoue Y

Neuropsychiatric Disease and Treatment 2015, 11:2953-2958

Published Date: 25 November 2015

Comparative efficacy, acceptability, and tolerability of dexmethylphenidate versus placebo in child and adolescent ADHD: a meta-analysis of randomized controlled trials

Maneeton N, Maneeton B, Woottiluk P, Suttajit S, Likhitsathian S, Charnsil C, Srisurapanont M

Neuropsychiatric Disease and Treatment 2015, 11:2943-2952

Published Date: 25 November 2015

The association between the subjective memory complaints scale and depressive state and cognitive impairment: a factor analysis

Tomita T, Yasui-Furukori N, Sugawara N, Takahashi I, Sawada K, Nakamura K

Neuropsychiatric Disease and Treatment 2015, 11:2935-2941

Published Date: 23 November 2015

Relationship between remnant hippocampus and amygdala and memory outcomes after stereotactic surgery for mesial temporal lobe epilepsy

Malikova H, Kramska L, Vojtech Z, Sroubek J, Lukavsky J, Liscak R

Neuropsychiatric Disease and Treatment 2015, 11:2927-2933

Published Date: 19 November 2015

Serum endocan levels in women with restless legs syndrome

Celik K, Cikrikcioglu MA, Halac G, Kilic E, Ayhan S, Ozaras N, Yildiz K, Yildiz RS, Zorlu M, Karatoprak C, Cakirca M, Kiskac M

Neuropsychiatric Disease and Treatment 2015, 11:2919-2925

Published Date: 19 November 2015

Prefrontocerebellar transcranial direct current stimulation increases amplitude and decreases latency of P3b component in patients with euthymic bipolar disorder

Bersani FS, Minichino A, Fattapposta F, Bernabei L, Spagnoli F, Mannarelli D, Francesconi M, Pauletti C, Corrado A, Vergnani L, Taddei I, Biondi M, Delle Chiaie R

Neuropsychiatric Disease and Treatment 2015, 11:2913-2917

Published Date: 19 November 2015

Atomoxetine treatment may decrease striatal dopaminergic transporter availability after 8 weeks: pilot SPECT report of three cases

Akay AP, Kaya GC, Baykara B, Demir Y, Ozek H, Alsen S, Eren MS, Emiroglu NI, Ertay T, Ozturk Y, Miral S, Durak H, Tufan E

Neuropsychiatric Disease and Treatment 2015, 11:2909-2912

Published Date: 19 November 2015

Association between insulin and executive functioning in alcohol dependence: a pilot study

Han C, Bae H, Won SD, Lim J, Kim DJ

Neuropsychiatric Disease and Treatment 2015, 11:2903-2908

Published Date: 16 November 2015

Paroxetine ameliorates changes in hippocampal energy metabolism in chronic mild stress-exposed rats

Khedr LH, Nassar NN, El-Denshary ES, Abdel-tawab AM

Neuropsychiatric Disease and Treatment 2015, 11:2887-2901

Published Date: 13 November 2015

Memantine for the treatment of frontotemporal dementia: a meta-analysis

Kishi T, Matsunaga S, Iwata N

Neuropsychiatric Disease and Treatment 2015, 11:2883-2885

Published Date: 12 November 2015

The ability of early changes in motivation to predict later antidepressant treatment response

Gorwood P, Vaiva G, Corruble E, Llorca PM, Baylé FJ, Courtet P

Neuropsychiatric Disease and Treatment 2015, 11:2875-2882

Published Date: 11 November 2015

The impact of nonmotor symptoms on quality of life in patients with Parkinson's disease in Taiwan

Liu WM, Lin RJ, Yu RL, Tai CH, Lin CH, Wu RM

Neuropsychiatric Disease and Treatment 2015, 11:2865-2873

Published Date: 11 November 2015

Early stages of pediatric bipolar disorder: retrospective analysis of a Czech inpatient sample

Goetz M, Novak T, Vesela M, Hlavka Z, Brunovsky M, Povazan M, Ptacek R, Sebela A

Neuropsychiatric Disease and Treatment 2015, 11:2855-2864

Published Date: 4 November 2015

Frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease

Cui F, Zhu WJ, Zhou ZB, Ren Y, Li YF, Li M, Huo YY, Huang XS

Neuropsychiatric Disease and Treatment 2015, 11:2847-2854

Published Date: 3 November 2015

In vitro screening of major neurotransmitter systems possibly involved in the mechanism of action of antibodies to S100 protein in released-active form

Gorbunov EA, Ertuzun IA, Kachaeva EV, Tarasov SA, Epstein OI

Neuropsychiatric Disease and Treatment 2015, 11:2837-2846

Published Date: 3 November 2015

Double encephalitis with herpes simplex virus type II and cytomegalovirus in an elder Chinese: a case report

Xue C, Chen S, Lin Q, Zhou H, Huang C, Lin J, Xie W, Chen K, Zhou D, Ma W, Ma F, Xu H

Neuropsychiatric Disease and Treatment 2015, 11:2833-2836

Published Date: 2 November 2015

Neurological soft signs might be endophenotype candidates for patients with deficit syndrome schizophrenia

Albayarak Y, Akyol ES, Beyazyüz M, Baykal S, Kuloglu M

Neuropsychiatric Disease and Treatment 2015, 11:2825-2831

Published Date: 29 October 2015

Reliability and validity of the Thai self-report version of the Yale–Brown Obsessive–Compulsive Scale-Second Edition

Hiranyatheb T, Saipanish R, Lotrakul M, Prasertchai R, Ketkaew W, Jullagate S, Udomsubpayakul U, Kusalaruk P

Neuropsychiatric Disease and Treatment 2015, 11:2817-2824

Published Date: 28 October 2015

The low level of understanding of depression among patients treated with antidepressants: a survey of 424 outpatients in Japan

Kudo S, Tomita T, Sugawara N, Sato Y, Ishioka M, Tsuruga K, Nakagami T, Nakamura K, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2015, 11:2811-2816

Published Date: 28 October 2015

Connectomics in psychiatric research: advances and applications

Cao M, Wang Z, He Y

Neuropsychiatric Disease and Treatment 2015, 11:2801-2810

Published Date: 29 October 2015

Association study of sepiapterin reductase gene promoter polymorphisms with schizophrenia in a Han Chinese population

Fu JW, Ma GD, Mai H, Luo XD, Yin JW, Chen Q, Lin ZX, Tao H, Li Y, Cui LL, Li Z, Lin JD, Zhao B, Li KS

Neuropsychiatric Disease and Treatment 2015, 11:2793-2799

Published Date: 28 October 2015

Efficacy of physical activity counseling plus sleep restriction therapy on the patients with chronic insomnia

Wang J, Yin G, Li G, Liang W, Wei Q

Neuropsychiatric Disease and Treatment 2015, 11:2771-2778

Published Date: 23 October 2015

Electroencephalography signatures of attention-deficit/hyperactivity disorder: clinical utility

Alba G, Pereda E, Mañas S, Méndez LD, González A, González JJ

Neuropsychiatric Disease and Treatment 2015, 11:2755-2769

Published Date: 22 October 2015

Epidemiological support for genetic variability at hypothalamic–pituitary–adrenal axis and serotonergic system as risk factors for major depression

Ching-López A, Cervilla J, Rivera M, Molina E, McKenney K, Ruiz-Perez I, Rodríguez-Barranco M, Gutiérrez B

Neuropsychiatric Disease and Treatment 2015, 11:2743-2754

Published Date: 22 October 2015

Frequency of anemia in chronic psychiatry patients

Korkmaz S, Yıldız S, Korucu T, Gundogan B, Sunbul ZE, Korkmaz H, Atmaca M

Neuropsychiatric Disease and Treatment 2015, 11:2737-2741

Published Date: 22 October 2015

Neuropsychological and neuroimaging markers in prediction of cognitive impairment after ischemic stroke: a prospective follow-up study

Mehrabian S, Raycheva M, Petrova N, Janyan A, Petrova M, Traykov L

Neuropsychiatric Disease and Treatment 2015, 11:2711-2719

Published Date: 16 October 2015

Motivation for everyday social participation in cognitively able individuals with autism spectrum disorder

Chen YW, Bundy AC, Cordier R, Chien YL, Einfeld SL

Neuropsychiatric Disease and Treatment 2015, 11:2699-2709

Published Date: 15 October 2015

Neurobehavioral burden of multiple sclerosis with nanotheranostics

Sriramoju B, Kanwar RK, Kanwar JR

Neuropsychiatric Disease and Treatment 2015, 11:2675-2689

Published Date: 15 October 2015

Off-label use of transmucosal ketamine as a rapid-acting antidepressant: a retrospective chart review

Nguyen L, Marshalek PJ, Weaver CB, Cramer KJ, Pollard SE, Matsumoto RR

Neuropsychiatric Disease and Treatment 2015, 11:2667-2673

Published Date: 14 October 2015

Altered regional homogeneity of spontaneous brain activity in idiopathic trigeminal neuralgia

Wang Y, Zhang X, Guan Q, Wan L, Yi Y, Liu CF

Neuropsychiatric Disease and Treatment 2015, 11:2659-2666

Published Date: 13 October 2015

Aripiprazole: from pharmacological profile to clinical use

Di Sciascio G, Riva MA

Neuropsychiatric Disease and Treatment 2015, 11:2635-2647

Published Date: 13 October 2015

Increased mean platelet volume in patients with panic disorder

Kokacya MH, Copoglu US, Kivrak Y, Ari M, Sahpolat M, Ulutas KT

Neuropsychiatric Disease and Treatment 2015, 11:2629-2633

Published Date: 13 October 2015

Heart rate variability biofeedback in patients with alcohol dependence: a randomized controlled study

Penzlin AI, Siepmann T, Illigens BMW, Weidner K, Siepmann M

Neuropsychiatric Disease and Treatment 2015, 11:2619-2627

Published Date: 9 October 2015

Predictors of trauma in bank employee robbery victims

Mucci N, Giorgi G, Fiz Perez J, Iavicoli I, Arcangeli G

Neuropsychiatric Disease and Treatment 2015, 11:2605-2612

Published Date: 7 October 2015

Cognitive reserve and Aβ1-42 in mild cognitive impairment (Argentina-Alzheimer’s Disease Neuroimaging Initiative)

Harris P, Fernandez Suarez M, Surace EI, Chrem Méndez P, Martín ME, Clarens MF, Tapajóz F, Russo MJ, Campos J, Guinjoan SM, Sevlever G, Allegri RF

Neuropsychiatric Disease and Treatment 2015, 11:2599-2604

Published Date: 7 October 2015

Clinical correlates of complicated grief among individuals with acute coronary syndromes

Pini S, Gesi C, Abelli M, Cardini A, Lari L, Felice F, Di Stefano R, Mazzotta G, Bovenzi F, Bertoli D, Borelli L, Michi P, Oligeri C, Balbarini A, Manicavasagar V

Neuropsychiatric Disease and Treatment 2015, 11:2583-2589

Published Date: 7 October 2015

Variation of the default mode network with altered alertness levels induced by propofol

Liu XY, Li HD, Luo F, Zhang L, Han RQ, Wang BG

Neuropsychiatric Disease and Treatment 2015, 11:2573-2581

Published Date: 7 October 2015

Electroconvulsive therapy treatment in patients with somatic symptom and related disorders

Leong KW, Tham JCW, Scamvougeras A, Vila-Rodriguez F

Neuropsychiatric Disease and Treatment 2015, 11:2565-2572

Published Date: 6 October 2015

Effect of depressive symptoms on the length of hospital stay among patients hospitalized for acute stroke in Japan

Sugawara N, Metoki N, Hagii J, Saito S, Shiroto H, Tomita T, Yasujima M, Okumura K, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2015, 11:2551-2556

Published Date: 5 October 2015

Psychogenic non-epileptic seizures: so-called psychiatric comorbidity and underlying defense mechanisms

Beghi M, Beffa Negrini P, Perin C, Peroni F, Magaudda A, Cerri C, Cornaggia CM

Neuropsychiatric Disease and Treatment 2015, 11:2519-2527

Published Date: 30 September 2015

Depressogenic medications and other risk factors for depression among Polish patients with epilepsy

Bosak M, Turaj W, Dudek D, Siwek M, Szczudlik A

Neuropsychiatric Disease and Treatment 2015, 11:2509-2517

Published Date: 30 September 2015

A meta-analysis of lipid peroxidation markers in major depression

Mazereeuw G, Herrmann N, Andreazza AC, Khan MM, Lanctôt KL

Neuropsychiatric Disease and Treatment 2015, 11:2479-2491

Published Date: 29 September 2015

Psychosocial functioning in schizophrenia: are some symptoms or demographic characteristics predictors across the functioning domains?

Suttajit S, Arunpongpaisal S, Srisurapanont M, Thavichachart N, Kongsakon R, Chantakarn S, Chantarasak V, Jariyavilas A, Jaroensook P, Kittiwattanagul K, Nerapusee O

Neuropsychiatric Disease and Treatment 2015, 11:2471-2477

Published Date: 29 September 2015

Metric qualities of the cognitive behavioral assessment for outcome evaluation to estimate psychological treatment effects

Bertolotti G, Michielin P, Vidotto G, Sanavio E, Bottesi G, Bettinardi O, Zotti AM

Neuropsychiatric Disease and Treatment 2015, 11:2449-2460

Published Date: 24 September 2015

First-time admissions for opioid treatment: cross-sectional and descriptive study of new opioid users seeking treatment

Flórez G, López-Durán A, Triñanes Y, Osorio J, Fraga J, Fernández JM, Becoña E, Arrojo M

Neuropsychiatric Disease and Treatment 2015, 11:2431-2440

Published Date: 24 September 2015

Linking emotional distress to unhealthy sleep duration: analysis of the 2009 National Health Interview Survey

Seixas AA, Nunes JV, Airhihenbuwa CO, Williams NJ, Pandi-Perumal SR, James CC, Jean-Louis G

Neuropsychiatric Disease and Treatment 2015, 11:2425-2430

Published Date: 25 September 2015

Anatomical and functional brain abnormalities in unmedicated major depressive disorder

Yang X, Ma X, Li M, Liu Y, Zhang J, Huang B, Zhao L, Deng W, Li T, Ma X

Neuropsychiatric Disease and Treatment 2015, 11:2415-2423

Published Date: 18 September 2015

Intractable and highly active relapsing multiple sclerosis – role of alemtuzumab

Dubey D, Cano CA, Stuve O

Neuropsychiatric Disease and Treatment 2015, 11:2405-2414

Published Date: 18 September 2015

An innovative intervention for the treatment of cognitive impairment–Emisymmetric bilateral stimulation improves cognitive functions in Alzheimer’s disease and mild cognitive impairment: an open-label study

Guerriero F, Botarelli E, Mele G, Polo L, Zoncu D, Renati P, Sgarlata C, Rollone M, Ricevuti G, Maurizi N, Francis M, Rondanelli M, Perna S, Guido D, Mannu P

Neuropsychiatric Disease and Treatment 2015, 11:2391-2404

Published Date: 18 September 2015

Preliminary findings on the reliability and validity of the Cantonese Birmingham Cognitive Screen in patients with acute ischemic stroke

Pan X, Chen H, Bickerton WL, Lau JKL, Kong APH, Rotshtein P, Guo A, Hu J, Humphreys GW

Neuropsychiatric Disease and Treatment 2015, 11:2377-2390

Published Date: 16 September 2015

Prediction by data mining, of suicide attempts in Korean adolescents: a national study

Bae SM, Lee SA, Lee SH

Neuropsychiatric Disease and Treatment 2015, 11:2367-2375

Published Date: 16 September 2015

Alzheimer's disease and its treatment costs: case study in the Czech Republic

Mohelska H, Maresova P, Valis M, Kuca K

Neuropsychiatric Disease and Treatment 2015, 11:2349-2354

Published Date: 11 September 2015

Augmentation of light therapy in difficult-to-treat depressed patients: an open-label trial in both unipolar and bipolar patients

Camardese G, Leone B, Serrani R, Walstra C, Di Nicola M, Della Marca G, Bria P, Janiri L

Neuropsychiatric Disease and Treatment 2015, 11:2331-2338

Published Date: 9 September 2015

Periodic limb movements during REM sleep in multiple sclerosis: a previously undescribed entity

Veauthier C, Gaede G, Radbruch H, Sieb JP, Wernecke KD, Paul F

Neuropsychiatric Disease and Treatment 2015, 11:2323-2329

Published Date: 9 September 2015

Identification of two novel mutations, PSEN1 E280K and PRNP G127S, in a Malaysian family

Ch’ng GS, An SSA, Bae SO, Bagyinszky E, Kim SY

Neuropsychiatric Disease and Treatment 2015, 11:2315-2322

Published Date: 8 September 2015

Platelet activating factors are associated with depressive symptoms in coronary artery disease patients: a hypothesis-generating study

Mazereeuw G, Herrmann N, Xu H, Blanchard AP, Figeys D, Oh PI, Bennett SAL, Lanctôt KL

Neuropsychiatric Disease and Treatment 2015, 11:2309-2314

Published Date: 4 September 2015

Value of F-wave studies on the electrodiagnosis of carpal tunnel syndrome

Alemdar M

Neuropsychiatric Disease and Treatment 2015, 11:2279-2286

Published Date: 31 August 2015

Prefronto–cerebellar transcranial direct current stimulation improves visuospatial memory, executive functions, and neurological soft signs in patients with euthymic bipolar disorder

Minichino A, Bersani FS, Bernabei L, Spagnoli F, Vergnani L, Corrado A, Taddei I, Biondi M, Delle Chiaie R

Neuropsychiatric Disease and Treatment 2015, 11:2265-2270

Published Date: 28 August 2015

Addiction profile in probation practices in Turkey: 5-year data analysis

Yazici AB, Yazici E, Akkisi Kumsar N, Erol A

Neuropsychiatric Disease and Treatment 2015, 11:2259-2263

Published Date: 27 August 2015

Neutrophil-lymphocyte ratio in patients with major depressive disorder undergoing no pharmacological therapy

Demir S, Atli A, Bulut M, İbiloğlu AO, Güneş M, Kaya MC, Demirpençe Ö, Sır A

Neuropsychiatric Disease and Treatment 2015, 11:2253-2258

Published Date: 27 August 2015

The impact of the duration of an untreated episode on improvement of depression and somatic symptoms

Hung CI, Yu NW, Liu CY, Wu KY, Yang CH

Neuropsychiatric Disease and Treatment 2015, 11:2245-2252

Published Date: 27 August 2015

Serum 25-hydroxyvitamin D predicts cognitive performance in adults

Darwish H, Zeinoun P, Ghusn H, Khoury B, Tamim H, Khoury SJ

Neuropsychiatric Disease and Treatment 2015, 11:2217-2223

Published Date: 25 August 2015

The association between sleep patterns and overweight/obesity in Chinese children: a cross-sectional study

Zhang B, Hao YL, Zhou JY, Jia FJ, Li XL, Tang Y, Zheng HR

Neuropsychiatric Disease and Treatment 2015, 11:2209-2216

Published Date: 24 August 2015

Epidemiology and clinical presentation of stroke in Upper Egypt (desert area)

El Tallawy HN, Farghaly WM, Badry R, Hamdy NA, Shehata GA, Rageh TA, Metwally NA, Hassan EM, Elsayed SS, Yehia MA, Soliman WT

Neuropsychiatric Disease and Treatment 2015, 11:2177-2183

Published Date: 21 August 2015

Psychiatric symptoms and leptin in obese patients who were bariatric surgery candidates

Changchien TC, Tai CM, Huang CK, Chien CC, Yen YC

Neuropsychiatric Disease and Treatment 2015, 11:2153-2158

Published Date: 19 August 2015

Lurasidone for the treatment of bipolar depression: an evidence-based review

Franklin R, Zorowitz S, Corse AK, Widge AS, Deckersbach T

Neuropsychiatric Disease and Treatment 2015, 11:2143-2152

Published Date: 19 August 2015

Employment and the associated impact on quality of life in people diagnosed with schizophrenia

Bouwmans C, de Sonneville C, Mulder CL, Hakkaart-van Roijen L

Neuropsychiatric Disease and Treatment 2015, 11:2125-2142

Published Date: 18 August 2015

Misophonia: current perspectives

Cavanna AE, Seri S

Neuropsychiatric Disease and Treatment 2015, 11:2117-2123

Published Date: 18 August 2015

Childhood adversities and laboratory pain perception

Pieritz K, Rief W, Euteneuer F

Neuropsychiatric Disease and Treatment 2015, 11:2109-2116

Published Date: 19 August 2015

Autophagy dysfunction upregulates beta-amyloid peptides via enhancing the activity of γ-secretase complex

Cai Z, Zhou Y, Liu Z, Ke Z, Zhao B

Neuropsychiatric Disease and Treatment 2015, 11:2091-2099

Published Date: 17 August 2015

The structural equation analysis of childhood abuse, adult stressful life events, and temperaments in major depressive disorders and their influence on refractoriness

Toda H, Inoue T, Tsunoda T, Nakai Y, Tanichi M, Tanaka T, Hashimoto N, Nakato Y, Nakagawa S, Kitaichi Y, Mitsui N, Boku S, Tanabe H, Nibuya M, Yoshino A, Kusumi I

Neuropsychiatric Disease and Treatment 2015, 11:2079-2090

Published Date: 12 August 2015

Poor mental health status and aggression are associated with poor driving behavior among male traffic offenders

Abdoli N, Farnia V, Delavar A, Esmaeili A, Dortaj F, Farrokhi N, Karami M, Shakeri J, Holsboer-Trachsler E, Brand S

Neuropsychiatric Disease and Treatment 2015, 11:2071-2078

Published Date: 11 August 2015

Mental health status, aggression, and poor driving distinguish traffic offenders from non-offenders but health status predicts driving behavior in both groups

Abdoli N, Farnia V, Delavar A, Esmaeili A, Dortaj F, Farrokhi N, Karami M, Shakeri J, Holsboer-Trachsler E, Brand S

Neuropsychiatric Disease and Treatment 2015, 11:2063-2070

Published Date: 10 August 2015

Adult attention-deficit hyperactivity disorder, risky behaviors, and motorcycle injuries: a case-control study

Sadeghi-Bazargani H, Abedi L, Mahini M, Amiri S, Khorasani-Zavareh D

Neuropsychiatric Disease and Treatment 2015, 11:2049-2054

Published Date: 7 August 2015

Relationship between cognitive insight and subjective quality of life in outpatients with schizophrenia

Kim JH, Lee S, Han AY, Kim K, Lee J

Neuropsychiatric Disease and Treatment 2015, 11:2041-2048

Published Date: 7 August 2015

Relationship between cobalamin deficiency and delirium in elderly patients undergoing cardiac surgery

Sevuk U, Baysal E, Ay N, Altas Y, Altindag R, Yaylak B, Alp V, Demirtas E

Neuropsychiatric Disease and Treatment 2015, 11:2033-2039

Published Date: 7 August 2015

Pain perception in schizophrenia: influence of neuropeptides, cognitive disorders, and negative symptoms

Urban-Kowalczyk M, Pigońska J, Śmigielski J

Neuropsychiatric Disease and Treatment 2015, 11:2023-2031

Published Date: 6 August 2015

Rare and very rare adverse effects of clozapine

De Fazio P, Gaetano R, Caroleo M, Cerminara G, Maida F, Bruno A, Muscatello MR, Jaén Moreno MJ, Russo E, Segura-García C

Neuropsychiatric Disease and Treatment 2015, 11:1995-2003

Published Date: 6 August 2015

The cost reduction in hospitalization associated with paliperidone palmitate in the People’s Republic of China, Korea, and Malaysia

Chiou CF, Wang BCM, Caldwell R, Furnback W, Lee JS, Kothandaraman N, Lee SK, Wang J, Zhang F

Neuropsychiatric Disease and Treatment 2015, 11:1989-1994

Published Date: 5 August 2015

Case-control association study of ABCB1 gene and major depressive disorder in a local Chinese Han population

Xie WW, Zhang L, Wu RR, Yu Y, Zhao JP, Li LH

Neuropsychiatric Disease and Treatment 2015, 11:1967-1971

Published Date: 4 August 2015

Evaluation of the efficacy and safety of vilazodone for treating major depressive disorder

Zhang XF, Wu L, Wan DJ, Liu RZ, Dong Z, Chen M, Yu SY

Neuropsychiatric Disease and Treatment 2015, 11:1957-1965

Published Date: 4 August 2015

Animal models of obsessive–compulsive disorder: utility and limitations

Alonso P, López-Solà C, Real E, Segalàs C, Menchón JM

Neuropsychiatric Disease and Treatment 2015, 11:1939-1955

Published Date: 4 August 2015

Piano training in youths with hand motor impairments after damage to the developing brain

Lampe R, Thienel A, Mitternacht J, Blumenstein T, Turova V, Alves-Pinto A

Neuropsychiatric Disease and Treatment 2015, 11:1929-1938

Published Date: 3 August 2015

A family-oriented treatment program for youths with ketamine abuse and their caregivers: a pilot study in Taiwan

Wang LJ, Lu SF, Chou WJ, Chong MY, Wang YH, Hsieh YL, Lee YH, Chen C

Neuropsychiatric Disease and Treatment 2015, 11:1921-1927

Published Date: 31 July 2015

Impact of aerobic exercise on sleep and motor skills in children with autism spectrum disorders – a pilot study

Brand S, Jossen S, Holsboer-Trachsler E, Pühse U, Gerber M

Neuropsychiatric Disease and Treatment 2015, 11:1911-1920

Published Date: 5 August 2015

Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice

Dell’Osso B, Albert U, Atti AR, Carmassi C, Carrà G, Cosci F, Del Vecchio V, Di Nicola M, Ferrari S, Goracci A, Iasevoli F, Luciano M, Martinotti G, Nanni MG, Nivoli A, Pinna F, Poloni N, Pompili M, Sampogna G, Tarricone I, Tosato S, Volpe U, Fiorillo A

Neuropsychiatric Disease and Treatment 2015, 11:1885-1909

Published Date: 30 July 2015

Disturbed spontaneous brain activity pattern in patients with primary angle-closure glaucoma using amplitude of low-frequency fluctuation: a fMRI study

Huang X, Zhong YL, Zeng XJ, Zhou F, Liu XH, Hu PH, Pei CG, Shao Y, Dai XJ

Neuropsychiatric Disease and Treatment 2015, 11:1877-1883

Published Date: 29 July 2015

Differential effects of dopamine-directed treatments on cognition

Ashby FG, Valentin VV, von Meer SS

Neuropsychiatric Disease and Treatment 2015, 11:1859-1875

Published Date: 29 July 2015

Association between toll-like receptor 4 expression and symptoms of major depressive disorder

Wu MK, Huang TL, Huang KW, Huang YL, Hung YY

Neuropsychiatric Disease and Treatment 2015, 11:1853-1857

Published Date: 30 July 2015

Genetic association between G protein-coupled receptor kinase 6/β-arrestin 2 and dopamine supersensitivity psychosis in schizophrenia

Oda Y, Kanahara N, Kimura H, Watanabe H, Hashimoto K, Iyo M

Neuropsychiatric Disease and Treatment 2015, 11:1845-1851

Published Date: 29 July 2015

Pituitary dysfunction following traumatic brain injury: clinical perspectives

Tanriverdi F, Kelestimur F

Neuropsychiatric Disease and Treatment 2015, 11:1835-1843

Published Date: 27 July 2015

Altered blood oxygen level-dependent signal variability in chronic post-traumatic stress disorder during symptom provocation

Ke J, Zhang L, Qi R, Xu Q, Li W, Hou C, Zhong Y, Zhang Z, He Z, Li L, Lu G

Neuropsychiatric Disease and Treatment 2015, 11:1805-1815

Published Date: 23 July 2015

Markers of neurodevelopmental impairments in early-onset psychosis

Petruzzelli MG, Margari L, Craig F, Campa MG, Martinelli D, Pastore A, Simone M, Margari F

Neuropsychiatric Disease and Treatment 2015, 11:1793-1798

Published Date: 20 July 2015

Effects of maintenance lithium treatment on serum parathyroid hormone and calcium levels: a retrospective longitudinal naturalistic study

Albert U, De Cori D, Aguglia A, Barbaro F, Lanfranco F, Bogetto F, Maina G

Neuropsychiatric Disease and Treatment 2015, 11:1785-1791

Published Date: 20 July 2015

Individual correlates of self-stigma in patients with anxiety disorders with and without comorbidities

Ociskova M, Prasko J, Kamaradova D, Grambal A, Sigmundova Z

Neuropsychiatric Disease and Treatment 2015, 11:1767-1779

Published Date: 17 July 2015

Role of apolipoprotein E in neurodegenerative diseases

Giau VV, Bagyinszky E, An SS, Kim SY

Neuropsychiatric Disease and Treatment 2015, 11:1723-1737

Published Date: 16 July 2015

Stress, anxiety, and depression among medical students in a multiethnic setting

Kulsoom B, Afsar NA

Neuropsychiatric Disease and Treatment 2015, 11:1713-1722

Published Date: 16 July 2015

Attitudes of psychiatrists toward obsessive–compulsive disorder patients

Kusalaruk P, Saipanish R, Hiranyatheb T

Neuropsychiatric Disease and Treatment 2015, 11:1703-1711

Published Date: 15 July 2015

Microribonucleic acid dysregulations in children and adolescents with obsessive–compulsive disorder

Kandemir H, Erdal ME, Selek S, İzci Ay Ö, Karababa İF, Ay ME, Kandemir SB, Yılmaz ŞG, Ekinci S, Taşdelen B, Bayazit H

Neuropsychiatric Disease and Treatment 2015, 11:1695-1701

Published Date: 14 July 2015

Relationship between apathy and tumor location, size, and brain edema in patients with intracranial meningioma

Peng Y, Shao C, Gong Y, Wu X, Tang W, Shi S

Neuropsychiatric Disease and Treatment 2015, 11:1685-1693

Published Date: 13 July 2015

Differences in maladaptive schemas between patients suffering from chronic and acute posttraumatic stress disorder and healthy controls

Ahmadian A, Mirzaee J, Omidbeygi M, Holsboer-Trachsler E, Brand S

Neuropsychiatric Disease and Treatment 2015, 11:1677-1684

Published Date: 10 July 2015

Early-onset anorexia nervosa in girls with Asperger syndrome

Dudova I, Kocourkova J, Koutek J

Neuropsychiatric Disease and Treatment 2015, 11:1639-1643

Published Date: 2 July 2015

The reduction of volume and fiber bundle connections in the hippocampus of EGR3 transgenic schizophrenia rats

Ma E, Song T, Zhang H, Lu J, Wang L, Zhao Q, Guo R, Li M, Ma G, Lu G, Li K

Neuropsychiatric Disease and Treatment 2015, 11:1625-1638

Published Date: 1 July 2015

Jumping to conclusions in schizophrenia

Evans SL, Averbeck BB, Furl N

Neuropsychiatric Disease and Treatment 2015, 11:1615-1624

Published Date: 1 July 2015

Epidemiological investigation of 264 sporadic cases of ruptured cerebral aneurysm at a single institution in southwest China

Liu H, Zhang TJ, Jiao S, Li BG, Guan J, Wang YX

Neuropsychiatric Disease and Treatment 2015, 11:1609-1614

Published Date: 1 July 2015

Diagnostic and treatment challenges in traumatic brain injury patients with severe neuropsychiatric symptoms: insights into psychiatric practice

Lauterbach MD, Notarangelo PL, Nichols SJ, Lane KS, Koliatsos VE

Neuropsychiatric Disease and Treatment 2015, 11:1601-1607

Published Date: 1 July 2015

Clinical utility of brain stimulation modalities following traumatic brain injury: current evidence

Li S, Zaninotto AL, Neville IS, Paiva WS, Nunn D, Fregni F

Neuropsychiatric Disease and Treatment 2015, 11:1573-1586

Published Date: 30 June 2015

Korean Medication Algorithm for Bipolar Disorder 2014: comparisons with other treatment guidelines

Jeong JH, Lee JG, Kim MD, Sohn IK, Shim SH, Wang HR, Woo YS, Jon DI, Seo JS, Shin YC, Min KJ, Yoon BH, Bahk WM

Neuropsychiatric Disease and Treatment 2015, 11:1561-1571

Published Date: 26 June 2015

Transcranial magnetic stimulation for the treatment of major depression

Janicak PG, Dokucu ME

Neuropsychiatric Disease and Treatment 2015, 11:1549-1560

Published Date: 26 June 2015

The social functional outcome of being naturalistically treated with paliperidone extended-release in patients with schizophrenia

Nakagawa R, Ohnishi T, Kobayashi H, Wakamatsu A, Tanimura A, Morita K, Yamaoka T, Usui H, Ogawa Y, Fujino A, Yoshizawa K

Neuropsychiatric Disease and Treatment 2015, 11:1511-1521

Published Date: 22 June 2015

Validity and reliability of the Turkish version of CRAFFT Substance Abuse Screening Test among adolescents

Kandemir H, Aydemir Ö, Ekinci S, Selek S, Kandemir SB, Bayazit H

Neuropsychiatric Disease and Treatment 2015, 11:1505-1509

Published Date: 22 June 2015

Telomere length in blood cells is related to the chronicity, severity, and recurrence rate of schizophrenia

Pawelczyk T, Szymanska B, Grancow-Grabka M, Kotlicka-Antczak M, Pawelczyk A

Neuropsychiatric Disease and Treatment 2015, 11:1493-1503

Published Date: 22 June 2015

Quetiapine mitigates the ethanol-induced oxidative stress in brain tissue, but not in the liver, of the rat

Han JH, Tian HZ, Lian YY, Yu Y, Lu CB, Li XM, Zhang RL, Xu H

Neuropsychiatric Disease and Treatment 2015, 11:1473-1482

Published Date: 15 June 2015

Focus group reflections on the current and future state of cognitive assessment tools in geriatric health care

Whitehead JC, Gambino SA, Richter JD, Ryan JD

Neuropsychiatric Disease and Treatment 2015, 11:1455-1466

Published Date: 12 June 2015

An exploratory study of the association between SORL1 polymorphisms and sporadic Alzheimer’s disease in the Han Chinese population

Zhang F, Liu X, Wang B, Cheng Z, Zhao X, Zhu J, Wang D, Wang Y, Dong A, Li P, Jin C

Neuropsychiatric Disease and Treatment 2015, 11:1443-1448

Published Date: 12 June 2015

Anti-N-methyl-d-aspartate receptor encephalitis in a patient with a 7-year history of being diagnosed as schizophrenia: complexities in diagnosis and treatment

Huang C, Kang Y, Zhang B, Li B, Qiu C, Liu S, Ren H, Yang Y, Liu X, Li T, Guo W

Neuropsychiatric Disease and Treatment 2015, 11:1437-1442

Published Date: 11 June 2015

Undertreatment of human immunodeficiency virus in psychiatric inpatients: a cross-sectional study of seroprevalence and associated factors

Gonzalez-Torres MA, Salazar MA, Imaz M, Inchausti L, Ibañez B, Fernandez-Rivas A, Pastor J, Anguiano B, Muñoz P, Ruiz E, Oraa R, Bustamante S, Alvarez de Eulate S, Cisterna R

Neuropsychiatric Disease and Treatment 2015, 11:1421-1426

Published Date: 11 June 2015

Psychiatric symptoms in glioma patients: from diagnosis to management

Boele FW, Rooney AG, Grant R, Klein M

Neuropsychiatric Disease and Treatment 2015, 11:1413-1420

Published Date: 10 June 2015

Cognitive impairment in generalized anxiety disorder revealed by event-related potential N270

Yang Y, Zhang X, Zhu Y, Dai Y, Liu T, Wang Y

Neuropsychiatric Disease and Treatment 2015, 11:1405-1411

Published Date: 3 June 2015

Association analysis of the Cadherin13 gene with schizophrenia in the Japanese population

Otsuka I, Watanabe Y, Hishimoto A, Boku S, Mouri K, Shiroiwa K, Okazaki S, Nunokawa A, Shirakawa O, Someya T, Sora I

Neuropsychiatric Disease and Treatment 2015, 11:1381-1393

Published Date: 2 June 2015

Predictors of quality of life among individuals with schizophrenia

Suttajit S, Pilakanta S

Neuropsychiatric Disease and Treatment 2015, 11:1371-1379

Published Date: 28 May 2015

Attitudes and beliefs of patients with chronic depression toward antidepressants and depression

Jacob SA, Ab Rahman AF, Hassali MA

Neuropsychiatric Disease and Treatment 2015, 11:1339-1347

Published Date: 27 May 2015

Ranitidine reduced levodopa-induced dyskinesia by remodeling neurochemical changes in hemiparkinsonian model of rats

Shi H, Yang X, Zhao H, Zhang S, Zu J, Zhang W, Shen X, Cui G, Hua F, Yan C

Neuropsychiatric Disease and Treatment 2015, 11:1331-1337

Published Date: 27 May 2015

Brain in flames – animal models of psychosis: utility and limitations

Mattei D, Schweibold R, Wolf SA

Neuropsychiatric Disease and Treatment 2015, 11:1313-1329

Published Date: 27 May 2015

Comparison of paroxetine and agomelatine in depressed type 2 diabetes mellitus patients: a double-blind, randomized, clinical trial

Kang RY, He Y, Yan YX, Li ZW, Wu YQ, Guo XJ, Liang ZG, Jiang J

Neuropsychiatric Disease and Treatment 2015, 11:1307-1311

Published Date: 27 May 2015

Efficacy and safety of aripiprazole once-monthly in obese and nonobese patients with schizophrenia: a post hoc analysis

De Hert M, Eramo A, Landsberg W, Kostic D, Tsai LF, Baker RA

Neuropsychiatric Disease and Treatment 2015, 11:1299-1306

Published Date: 27 May 2015

Being parents with epilepsy: thoughts on its consequences and difficulties affecting their children

Gauffin H, Flensner G, Landtblom AM

Neuropsychiatric Disease and Treatment 2015, 11:1291-1298

Published Date: 27 May 2015

The interventional effects of loving-kindness meditation on positive emotions and interpersonal interactions

He X, Shi W, Han X, Wang N, Zhang N, Wang X

Neuropsychiatric Disease and Treatment 2015, 11:1273-1277

Published Date: 25 May 2015

Comprehensive family therapy: an effective approach for cognitive rehabilitation in schizophrenia

Cai J, Zhu Y, Zhang W, Wang Y, Zhang C

Neuropsychiatric Disease and Treatment 2015, 11:1247-1253

Published Date: 21 May 2015

Efficacy and safety of intravenous nimodipine administration for treatment of hypertension in patients with intracerebral hemorrhage

Li YQ, Fang W, Tao L, Li M, Yang YL, Gao YF, Ge SN, Gao L, Zhang B, Li ZH, Zhou W, Wang BL, Li LH

Neuropsychiatric Disease and Treatment 2015, 11:1231-1238

Published Date: 19 May 2015

The relationship of psychological trauma with trichotillomania and skin picking

Özten E, Hızlı Sayar G, Eryılmaz G, Kağan G, Işık S, Karamustafalıoğlu O

Neuropsychiatric Disease and Treatment 2015, 11:1203-1210

Published Date: 15 May 2015

Coping strategies, hope, and treatment efficacy in pharmacoresistant inpatients with neurotic spectrum disorders

Ociskova M, Prasko J, Kamaradova D, Grambal A, Kasalova P, Sigmundova Z, Latalova K, Vrbova K

Neuropsychiatric Disease and Treatment 2015, 11:1191-1201

Published Date: 15 May 2015

Wearing-off in Parkinson’s disease: neuropsychological differences between on and off periods

Caillava-Santos F, Margis R, Rieder CR

Neuropsychiatric Disease and Treatment 2015, 11:1175-1180

Published Date: 13 May 2015

Evaluation of acute cardiovascular effects of immediate-release methylphenidate in children and adolescents with attention-deficit hyperactivity disorder

Lamberti M, Italiano D, Guerriero L, D’Amico G, Siracusano R, Ingrassia M, Germanò E, Calabrò MP, Spina E, Gagliano A

Neuropsychiatric Disease and Treatment 2015, 11:1169-1174

Published Date: 8 May 2015

Ataxia with Parkinsonism and dystonia after intentional inhalation of liquefied petroleum gas

Godani M, Canavese F, Migliorini S, Del Sette M

Neuropsychiatric Disease and Treatment 2015, 11:1157-1159

Published Date: 6 May 2015

Depressive disorders co-existing with Addison–Biermer anemia – case report

Just MJ, Kozakiewicz M

Neuropsychiatric Disease and Treatment 2015, 11:1145-1148

Published Date: 30 April 2015

Association between anxiety and hypertension: a systematic review and meta-analysis of epidemiological studies

Pan Y, Cai W, Cheng Q, Dong W, An T, Yan J

Neuropsychiatric Disease and Treatment 2015, 11:1121-1130

Published Date: 22 April 2015

Dietary patterns and schizophrenia: a comparison with healthy controls

Tsuruga K, Sugawara N, Sato Y, Saito M, Furukori H, Nakagami T, Nakamura K, Takahashi I, Nakaji S, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2015, 11:1115-1120

Published Date: 22 April 2015

Posterior reversible encephalopathy syndrome in a woman with focal segmental glomerulosclerosis

Chowdhary M, Kabbani AA, Tobey D, Hope TD

Neuropsychiatric Disease and Treatment 2015, 11:1111-1114

Published Date: 21 April 2015

Factors associated with poor discharge status in patients with status epilepticus at Khon Kaen hospital

Chiewthanakul P, Noppaklao P, Sawanyawisuth K, Tiamkao S

Neuropsychiatric Disease and Treatment 2015, 11:1097-1101

Published Date: 20 April 2015

Comorbid personality disorders among patients with depression

Wongpakaran N, Wongpakaran T, Boonyanaruthee V, Pinyopornpanish M, Intaprasert S

Neuropsychiatric Disease and Treatment 2015, 11:1091-1096

Published Date: 17 April 2015

Catha edulis chewing effects on treatment of paranoid schizophrenic patients

Kotb El-Sayed MI, Amin HK

Neuropsychiatric Disease and Treatment 2015, 11:1067-1076

Published Date: 15 April 2015

Current perspectives on deep brain stimulation for severe neurological and psychiatric disorders

Kocabicak E, Temel Y, Höllig A, Falkenburger B, Tan SK

Neuropsychiatric Disease and Treatment 2015, 11:1051-1066

Published Date: 9 April 2015

Prevalence of distorted body image in young Koreans and its association with age, sex, body weight status, and disordered eating behaviors

Hong SC, Jung YE, Kim MD, Lee CI, Hyun MY, Bahk WM, Yoon BH, Lee KH

Neuropsychiatric Disease and Treatment 2015, 11:1043-1049

Published Date: 9 April 2015

Social cognitive and neurocognitive deficits in inpatients with unilateral thalamic lesions — pilot study

Wilkos E, Brown TJ, Slawinska K, Kucharska KA

Neuropsychiatric Disease and Treatment 2015, 11:1031-1038

Published Date: 10 April 2015

Activation of mTOR: a culprit of Alzheimer’s disease?

Cai Z, Chen G, He W, Xiao M, Yan LJ

Neuropsychiatric Disease and Treatment 2015, 11:1015-1030

Published Date: 9 April 2015

Possible association between moderate intellectual disability and weight gain in valproic acid–treated patients with epilepsy

Tanamachi Y, Saruwatari J, Noai M, Kamihashi R, Soraoka H, Yoshimori Y, Ogusu N, Oniki K, Yasui-Furukori N, Ishitsu T, Nakagawa K

Neuropsychiatric Disease and Treatment 2015, 11:1007-1014

Published Date: 7 April 2015

“Recovery” from the diagnosis of autism – and then?

Barnevik Olsson M, Westerlund J, Lundström S, Giacobini M, Fernell E, Gillberg C

Neuropsychiatric Disease and Treatment 2015, 11:999-1005

Published Date: 7 April 2015

Factors associated with group bullying and psychopathology in elementary school students using child-welfare facilities

Kim JW, Lee K, Lee YS, Han DH, Min KJ, Song SH, Park GN, Lee JY, Kim JO

Neuropsychiatric Disease and Treatment 2015, 11:991-998

Published Date: 7 April 2015

Health care resource use and direct medical costs for patients with schizophrenia in Tianjin, People’s Republic of China

Wu J, He XN, Liu L, Ye W, Montgomery W, Xue HB, McCombs JS

Neuropsychiatric Disease and Treatment 2015, 11:983-990

Published Date: 7 April 2015

Neuromodulation and antenatal depression: a review

Kim DR, Snell JL, Ewing GC, O’Reardon J

Neuropsychiatric Disease and Treatment 2015, 11:975-982

Published Date: 7 April 2015

Psychosurgery for stuttering

Durand E, Weil AG, Lévêque M

Neuropsychiatric Disease and Treatment 2015, 11:963-965

Published Date: 2 April 2015

Catatonia in Down syndrome; a treatable cause of regression

Ghaziuddin N, Nassiri A, Miles JH

Neuropsychiatric Disease and Treatment 2015, 11:941-949

Published Date: 2 April 2015

Adherence and rehospitalizations in patients with schizophrenia: evidence from Japanese claims data

Kuwabara H, Saito Y, Mahlich J

Neuropsychiatric Disease and Treatment 2015, 11:935-940

Published Date: 1 April 2015

Use of second-generation antipsychotics in the acute inpatient management of schizophrenia in the Middle East

Alkhadhari S, Al Zain N, Darwish T, Khan S, Okasha T, Ramy H, Tadros TM

Neuropsychiatric Disease and Treatment 2015, 11:915-924

Published Date: 1 April 2015

A cross-sectional study on perception of stigma by Chinese schizophrenia patients [Retraction]

Ren ZB, Wang HQ, Feng B, Gu CY, Ma YC, Chen H, Li BL, Liu LY

Neuropsychiatric Disease and Treatment 2015, 11:895-896

Published Date: 1 April 2015

High prevalence of sleep and mood disorders in dry eye patients: survey of 1,000 eye clinic visitors

Ayaki M, Kawashima M, Negishi K, Tsubota K

Neuropsychiatric Disease and Treatment 2015, 11:889-894

Published Date: 31 March 2015

Aripiprazole-associated tic in a schizophrenia patient

Guo X, Lu D, Jiang Y

Neuropsychiatric Disease and Treatment 2015, 11:873-874

Published Date: 30 March 2015

Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndrome

Akyol ES, Albayrak Y, Beyazyüz M, Aksoy N, Kuloglu M, Hashimoto K

Neuropsychiatric Disease and Treatment 2015, 11:865-872

Published Date: 30 March 2015

Different presence of Chlamydia pneumoniae, herpes simplex virus type 1, human herpes virus 6, and Toxoplasma gondii in schizophrenia: meta-analysis and analytical study

Gutiérrez-Fernández J, Luna del Castillo JD, Mañanes-González S, Carrillo-Ávila JA, Gutiérrez B, Cervilla JA, Sorlózano-Puerto A

Neuropsychiatric Disease and Treatment 2015, 11:843-852

Published Date: 27 March 2015

Effects of prolonged head-down bed rest on working memory

Liu Q, Zhou R, Zhao X, Oei TPS

Neuropsychiatric Disease and Treatment 2015, 11:835-842

Published Date: 26 March 2015

Neurofibromatosis type 1 and attention deficit hyperactivity disorder: a case study and literature review

Miguel CS, Chaim-Avancini TM, Silva MA, Louzã MR

Neuropsychiatric Disease and Treatment 2015, 11:815-821

Published Date: 25 March 2015

Forehead carbuncle with intractable headache

Chou PY, Chen YC, Huang P

Neuropsychiatric Disease and Treatment 2015, 11:793-795

Published Date: 20 March 2015

Neuroinflammatory responses to traumatic brain injury

Paiva WS, Correia AD, Marie SK

Neuropsychiatric Disease and Treatment 2015, 11:773-776

Published Date: 19 March 2015

Optimal management of night eating syndrome: challenges and solutions

Kucukgoncu S, Midura M, Tek C

Neuropsychiatric Disease and Treatment 2015, 11:751-760

Published Date: 19 March 2015

Effects of a selective educational system on fatigue, sleep problems, daytime sleepiness, and depression among senior high school adolescents in Taiwan

Chen TY, Chou YC, Tzeng NS, Chang HA, Kuo SC, Pan PY, Yeh YW, Yeh CB, Mao WC

Neuropsychiatric Disease and Treatment 2015, 11:741-750

Published Date: 19 March 2015

Red cell distribution width and neurological scoring systems in acute stroke patients

Kara H, Degirmenci S, Bayir A, Ak A, Akinci M, Dogru A, Akyurek F, Kayis SA

Neuropsychiatric Disease and Treatment 2015, 11:733-739

Published Date: 18 March 2015

The influence of comorbid personality disorders on recovery from depression

Wongpakaran T, Wongpakaran N, Boonyanaruthee V, Pinyopornpanish M, Intaprasert S

Neuropsychiatric Disease and Treatment 2015, 11:725-732

Published Date: 16 March 2015

Association between pain severity, depression severity, and use of health care services in Japan: results of a nationwide survey

Vietri J, Otsubo T, Montgomery W, Tsuji T, Harada E

Neuropsychiatric Disease and Treatment 2015, 11:675-683

Published Date: 13 March 2015

Impact of incarceration in Nazi concentration camps on multimorbidity of former prisoners

Jablonski RK, Leszek J, Rosińczuk J, Uchmanowicz I, Panaszek B

Neuropsychiatric Disease and Treatment 2015, 11:669-674

Published Date: 11 March 2015

Efficacy, safety, and impact on hospitalizations of paliperidone palmitate in recent-onset schizophrenia

Zhang F, Si T, Chiou CF, Harris AWF, Kim CY, Jahagirdar P, Ascher S

Neuropsychiatric Disease and Treatment 2015, 11:657-668

Published Date: 11 March 2015

A retrospective study to assess resource utilization in patients with cervical dystonia in the United Kingdom

Raluy-Callado M, Gabriel S, Dinet J, Wang M, Wasiak R

Neuropsychiatric Disease and Treatment 2015, 11:647-655

Published Date: 9 March 2015

Anti-NMDA receptor antibodies in patients with a first episode of schizophrenia

Masopust J, Andrýs C, Bažant J, Vyšata O, Kuca K, Vališ M

Neuropsychiatric Disease and Treatment 2015, 11:619-623

Published Date: 6 March 2015

Buprenorphine, methadone, and morphine treatment during pregnancy: behavioral effects on the offspring in rats

Chen HH, Chiang YC, Yuan ZF, Kuo CC, Lai MD, Hung TW, Ho IK, Chen ST

Neuropsychiatric Disease and Treatment 2015, 11:609-618

Published Date: 6 March 2015

Changes in proinflammatory cytokines and white matter in chronically stressed rats

Yang P, Gao Z, Zhang H, Fang Z, Wu C, Xu H, Huang QJ

Neuropsychiatric Disease and Treatment 2015, 11:597-607

Published Date: 6 March 2015

Quality of life of patients with schizophrenia treated in foster home care and in outpatient treatment

Mihanović M, Restek-Petrović B, Bogović A, Ivezić E, Bodor D, Požgain I

Neuropsychiatric Disease and Treatment 2015, 11:585-595

Published Date: 5 March 2015

Sex differences in TGFB-β signaling with respect to age of onset and cognitive functioning in schizophrenia

Frydecka D, Misiak B, Pawlak-Adamska E, Karabon L, Tomkiewicz A, Sedlaczek P, Kiejna A, Beszłej JA

Neuropsychiatric Disease and Treatment 2015, 11:575-584

Published Date: 5 March 2015

Impaired mitochondrial energy metabolism as a novel risk factor for selective onset and progression of dementia in oldest-old subjects

Zhao W, Wang J, Varghese M, Ho L, Mazzola P, Haroutunian V, Katsel PL, Gibson GE, Levine S, Dubner L, Pasinetti GM

Neuropsychiatric Disease and Treatment 2015, 11:565-574

Published Date: 5 March 2015

Is it possible to use highly realistic virtual reality in the elderly? A feasibility study with image-based rendering

Benoit M, Guerchouche R, Petit PD, Chapoulie E, Manera V, Chaurasia G, Drettakis G, Robert P

Neuropsychiatric Disease and Treatment 2015, 11:557-563

Published Date: 3 March 2015

Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia

Ranjbar F, Sadeghi-Bazargani H, Niari Khams P, Arfaie A, Salari A, Farahbakhsh M

Neuropsychiatric Disease and Treatment 2015, 11:549-555

Published Date: 2 March 2015

Cattle encephalon glycoside and ignotin injection improves cognitive impairment in APPswe/PS1dE9 mice used as multitarget anti-Alzheimer’s drug candidates

Gao Y, Hu YZ, Li RS, Han ZT, Geng Y, Xia Z, Du WJ, Liu LX, Zhang HH, Wang LN

Neuropsychiatric Disease and Treatment 2015, 11:537-548

Published Date: 27 February 2015

Hypomania after augmenting venlafaxine and olanzapine with sarcosine in a patient with schizophrenia: a case study

Strzelecki D, Szyburska J, Kotlicka-Antczak M, Kałużyńska O

Neuropsychiatric Disease and Treatment 2015, 11:533-536

Published Date: 27 February 2015

Toward an online cognitive and emotional battery to predict treatment remission in depression

Gordon E, Rush AJ, Palmer DM, Braund TA, Rekshan W

Neuropsychiatric Disease and Treatment 2015, 11:517-531

Published Date: 26 February 2015

Korean Medication Algorithm Project for Bipolar Disorder: third revision

Woo YS, Lee JG, Jeong JH, Kim MD, Sohn IK, Shim SH, Jon DI, Seo JS, Shin YC, Min KJ, Yoon BH, Bahk WM

Neuropsychiatric Disease and Treatment 2015, 11:493-506

Published Date: 26 February 2015

A case-control proton magnetic resonance spectroscopy study confirms cerebellar dysfunction in benign adult familial myoclonic epilepsy

Long L, Song Y, Zhang L, Hu C, Gong J, Xu L, Long H, Zhou L, Zhang Y, Zhang Y, Xiao B

Neuropsychiatric Disease and Treatment 2015, 11:485-491

Published Date: 25 February 2015

Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers

Ishioka M, Yasui-Furukori N, Sugawara N, Furukori H, Kudo S, Nakamura K

Neuropsychiatric Disease and Treatment 2015, 11:477-484

Published Date: 24 February 2015

Coexistence of anxiety sensitivity and psychiatric comorbidities in patients with chronic tinnitus

Gül Aİ, Özkırış M, Aydın R, Şimşek G, Saydam L

Neuropsychiatric Disease and Treatment 2015, 11:413-418

Published Date: 19 February 2015

Untreated depression in the first trimester of pregnancy leads to postpartum depression: high rates from a natural follow-up study

Yazici E, Kirkan TS, Aslan PA, Aydin N, Yazici AB

Neuropsychiatric Disease and Treatment 2015, 11:405-411

Published Date: 19 February 2015

The clinical basis of orthorexia nervosa: emerging perspectives

Koven NS, Abry AW

Neuropsychiatric Disease and Treatment 2015, 11:385-394

Published Date: 18 February 2015

One-year follow-up in patients with brainstem infarction due to large-artery atherothrombosis

Kolukısa M, Ozdemir Gültekin T, Eryigit Baran G, Aralasmak A, Kocaman G, Gürsoy AE, Asil T

Neuropsychiatric Disease and Treatment 2015, 11:379-384

Published Date: 18 February 2015

Neurosyphilis with psychotic symptoms and Parkinsonism in a young girl

Yin L, Zou S, Huang Y

Neuropsychiatric Disease and Treatment 2015, 11:375-377

Published Date: 16 February 2015

MRI-guided stereotactic amygdalohippocampectomy: a single center experience

Vojtěch Z, Malíková H, Krámská L, Liščák R, Vladyka V

Neuropsychiatric Disease and Treatment 2015, 11:359-374

Published Date: 11 February 2015

Psychopathology, symptoms of attention-deficit/hyperactivity disorder, and risk factors in juvenile offenders

Margari F, Craig F, Margari L, Matera E, Lamanna AL, Lecce PA, La Tegola D, Carabellese F

Neuropsychiatric Disease and Treatment 2015, 11:343-352

Published Date: 10 February 2015

Common psychocutaneous disorders in children

Chiriac A, Brzezinski P, Pinteala T, Chiriac AE, Foia L

Neuropsychiatric Disease and Treatment 2015, 11:333-337

Published Date: 9 February 2015

Medium-to-high prevalence of screening-detected parkinsonism in the urban area of Tehran, Iran: data from a community-based door-to-door study

Fereshtehnejad SM, Shafieesabet M, Rahmani A, Delbari A, Lökk J

Neuropsychiatric Disease and Treatment 2015, 11:321-332

Published Date: 5 February 2015

Diffuse cerebral vasospasm after resection of schwannoma: a case report

Qi J,Zhang LW, Jia W, Zhang JT, Wu Z

Neuropsychiatric Disease and Treatment 2015, 11:317-320

Published Date: 5 February 2015

Neuroprotective strategies against calpain-mediated neurodegeneration

Yildiz-Unal A, Korulu S, Karabay A

Neuropsychiatric Disease and Treatment 2015, 11:297-310

Published Date: 5 February 2015

Adjunct effect of music therapy on cognition in Alzheimer’s disease in Taiwan: a pilot study

Li CH, Liu CK, Yang YH, Chou MC, Chen CH, Lai CL

Neuropsychiatric Disease and Treatment 2015, 11:291-296

Published Date: 4 February 2015

Increased expression of retinoic acid-induced gene 1 in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression

Haybaeck J, Postruznik M, Miller CL, Dulay JR, Llenos IC, Weis S

Neuropsychiatric Disease and Treatment 2015, 11:279-289

Published Date: 4 February 2015

Increased risk of posterior circulation infarcts among ischemic stroke patients with cervical spondylosis

Chen CC, Chung CY, Lee TH, Chang WH, Tang SF, Pei YC

Neuropsychiatric Disease and Treatment 2015, 11:273-278

Published Date: 3 February 2015

Perfectionism related to self-reported insomnia severity, but not when controlled for stress and emotion regulation

Brand S, Kirov R, Kalak N, Gerber M, Pühse U, Lemola S, Correll CU, Cortese S, Meyer T, Holsboer-Trachsler E

Neuropsychiatric Disease and Treatment 2015, 11:263-271

Published Date: 3 February 2015

Neural correlates of delusional infestation responding to aripiprazole monotherapy: a case report

Ponson L, Andersson F, El-Hage W

Neuropsychiatric Disease and Treatment 2015, 11:257-261

Published Date: 2 February 2015

Neuroinflammation in Alzheimer’s disease

Zhang FJ, Jiang LL

Neuropsychiatric Disease and Treatment 2015, 11:243-256

Published Date: 30 January 2015

The association of post-stroke anhedonia with salivary cortisol levels and stroke lesion in hippocampal/parahippocampal region

Terroni L, Amaro Jr E, Iosifescu DV, Mattos P, Yamamoto FI, Tinone G, Conforto AB, Sobreiro MFM, Guajardo VD, De Lucia MC, Moreira AC, Scaff M, Leite CC, Fraguas R

Neuropsychiatric Disease and Treatment 2015, 11:233-242

Published Date: 3 February 2015

Dilemma of prescribing aripiprazole under the Taiwan health insurance program: a descriptive study

Hsu YC, Chou YC, Chang HA, Kao YC, Huang SY, Tzeng NS

Neuropsychiatric Disease and Treatment 2015, 11:225-232

Published Date: 27 January 2015

Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational study

Novick D, Hong J, Montgomery W, Dueñas H, Gado M, Haro JM

Neuropsychiatric Disease and Treatment 2015, 11:197-205

Published Date: 22 January 2015

Hyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone

Hongkaew Y, Ngamsamut N, Puangpetch A, Vanwong N, Srisawasdi P, Chamnanphon M, Chamkrachchangpada B, Tan-kam T, Limsila P, Sukasem C

Neuropsychiatric Disease and Treatment 2015, 11:191-196

Published Date: 22 January 2015

The role of family therapy in the management of schizophrenia: challenges and solutions

Caqueo-Urízar A, Rus-Calafell M, Urzúa A, Escudero J, Gutiérrez-Maldonado J

Neuropsychiatric Disease and Treatment 2015, 11:145-151

Published Date: 14 January 2015

Acute effects of single and multiple level thoracic manipulations on chronic mechanical neck pain: a randomized controlled trial

Puntumetakul R, Suvarnnato T, Werasirirat P, Uthaikhup S, Yamauchi J, Boucaut R

Neuropsychiatric Disease and Treatment 2015, 11:137-144

Published Date: 12 January 2015

Levomilnacipran for the treatment of major depressive disorder: a review

Asnis GA, Henderson MA

Neuropsychiatric Disease and Treatment 2015, 11:125-135

Published Date: 9 January 2015

Efficacy comparison of duloxetine and SSRIs at doses approved in Japan

Harada E, Schacht A, Koyama T, Marangell LB, Tsuji T, Escobar R

Neuropsychiatric Disease and Treatment 2015, 11:115-123

Published Date: 12 January 2015

Association between subjective actual sleep duration, subjective sleep need, age, body mass index, and gender in a large sample of young adults

Kalak N, Brand S, Beck J, Holsboer-Trachsler E, Wollmer MA

Neuropsychiatric Disease and Treatment 2015, 11:107-113

Published Date: 9 January 2015

Neuroinflammatory responses to traumatic brain injury: etiology, clinical consequences, and therapeutic opportunities

Lozano D, Gonzales-Portillo GS, Acosta S, de la Pena I, Tajiri N, Kaneko Y, Borlongan CV

Neuropsychiatric Disease and Treatment 2015, 11:97-106

Published Date: 8 January 2015

The impact of internalizing symptoms on autistic traits in adolescents with restrictive anorexia nervosa

Calderoni S, Fantozzi P, Balboni G, Pagni V, Franzoni E, Apicella F, Narzisi A, Maestro S, Muratori F

Neuropsychiatric Disease and Treatment 2015, 11:75-85

Published Date: 5 January 2015

Prevalence of metabolic syndrome according to the presence of negative symptoms in patients with schizophrenia

Sicras-Mainar A, Maurino J, Ruiz-Beato E, Navarro-Artieda R

Neuropsychiatric Disease and Treatment 2015, 11:51-57

Published Date: 30 December 2014

A study of safety and tolerability of rotatory vestibular input for preschool children

Su WC, Lin CK, Chang SC

Neuropsychiatric Disease and Treatment 2015, 11:41-49

Published Date: 31 December 2014

Clinical preference for factors in treatment of geriatric depression

Riepe MW

Neuropsychiatric Disease and Treatment 2015, 11:25-31

Published Date: 22 December 2014

Cerebellar cryptococcosis characterized by a space-occupying lesion in an immunocompetent non-HIV patient

Liu BX, Dai XJ, Liu H, Gong HH, Wang YX, Zhang LL

Neuropsychiatric Disease and Treatment 2015, 11:21-24

Published Date: 19 December 2014

Exploring the risk-factor association between depression and incident stroke: a systematic review and meta-analysis

Barlinn K, Kepplinger J, Puetz V, Illigens BM, Bodechtel U, Siepmann T

Neuropsychiatric Disease and Treatment 2015, 11:1-14

Published Date: 18 December 2014